Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-22-012561

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 480,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER 2022-12-12 Grant or award · Stock Option (right to buy) +480,000 480,000 D
Loading xslF345X03/form4-12142022_111237.xml…